SAN DIEGO, Jan. 30, 2012 /PRNewswire/ -- Amylin
Pharmaceuticals, Inc. (Nasdaq: AMLN) will webcast its Quarterly
Update Conference Call for the fourth quarter and full year 2011 on
Monday, February 6, 2012 at
5:00 p.m. ET/2:00 p.m. PT. Daniel M.
Bradbury, Amylin's president and chief executive officer,
will lead the call. On the same date post-market, Amylin will
release financial results for the fourth quarter and year ended
December 31, 2011.
The call will be webcast live through the "Investors" section of
Amylin's corporate website and a recording will be made available
following the close of the call. To access the webcast, please log
on to www.amylin.com approximately 15 minutes prior to the call to
register, download and install any necessary audio software. For
those without access to the Internet, the live call may be accessed
by phone by calling (800) 857-5738 (U.S./Canada) or (415) 228-4970 (international),
participant passcode number 7253303. A replay of the call will also
be available by phone beginning approximately two hours after the
close of the call and can be accessed at (888) 673-3565
(U.S./Canada) or (402) 220-6428
(international).
About Amylin Pharmaceuticals
Amylin Pharmaceuticals is a biopharmaceutical company dedicated to
improving lives of patients through the discovery, development and
commercialization of innovative medicines. Amylin is committed to
delivering novel therapies that transform the way diabetes,
obesity, and related metabolic disorders are treated. Amylin is
headquartered in San Diego, Calif.
and has a commercial manufacturing facility in Ohio. More information on Amylin
Pharmaceuticals is available at www.amylin.com.
SOURCE Amylin Pharmaceuticals, Inc.